

@article {14965,
	title = {The final stages of the global eradication of poliomyelitis},
	journal = {Philos Trans R Soc Lond B Biol Sci},
	volume = {368},
	year = {2013},
	month = {aug},
	pages = {20120140},
	abstract = {The global incidence of poliomyelitis has dropped by more than 99 per cent since the governments of the world committed to eradication in 1988. One of the three serotypes of wild poliovirus has been eradicated and the remaining two serotypes are limited to just a small number of endemic regions. However, the Global Polio Eradication Initiative (GPEI) has faced a number of challenges in eradicating the last 1 per cent of wild-virus transmission. The polio endgame has also been complicated by the recognition that vaccination with the oral poliovirus vaccine (OPV) must eventually cease because of the risk of outbreaks of vaccine-derived polioviruses. I describe the major challenges to wild poliovirus eradication, focusing on the poor immunogenicity of OPV in lower-income countries, the inherent limitations to the sensitivity and specificity of surveillance, the international spread of poliovirus and resulting outbreaks, and the potential significance of waning intestinal immunity induced by OPV. I then focus on the challenges to eradicating all polioviruses, the problem of vaccine-derived polioviruses and the risk of wild-type or vaccine-derived poliovirus re-emergence after the cessation of oral vaccination. I document the role of research in the GPEI{\textquoteright}s response to these challenges and ultimately the feasibility of achieving a world without poliomyelitis.},
	keywords = {20th Century, 21st Century, Disease Eradication/history/*methods, History, Humans, Mass Vaccination/*methods, Oral/*history/immunology, Poliomyelitis/*history/*prevention \& control/transmission, Poliovirus Vaccine, Public Health/*methods/trends},
	issn = {1471-2970 (Electronic) 0962-8436 (Linking)},
	doi = {10.1098/rstb.2012.0140 rstb.2012.0140 [pii]},
	author = {Grassly, N. C.}
}
